Cargando…

Delivery of Lymph Node‐targeted Adriamycin by Gastric Submucosal Liposomal Injection in Rabbits

We investigated the feasibility of specifically delivering adriamycin (ADR) to the regional lymph nodes via gastric submucosal injection of liposomal adriamycin (Lipo‐ADR) in a rabbit model. We determined the tissue distribution of ADR for up to 7 days after the gastric submucosal injection of Lipo‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akamo, Yoshimi, Yotsuyanagi, Toshihisa, Mizuno, Isamu, Ichino, Tatsuo, Tanimoto, Noritaka, Kurahashi, Shingo, Saito, Takaaki, Yamamoto, Tetsuya, Yasui, Tamotsu, Itabashi, Yuji, Yura, Jiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919130/ https://www.ncbi.nlm.nih.gov/pubmed/8463137 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02857.x

Ejemplares similares

Antitumor Effect of Liposome‐entrapped Adriamycin Administered via the Portal Vein
por: Ichino, Tatsuo, et al.
Publicado: (1990)

Chemotherapy Targeting Regional Lymph Nodes by Gastric Submucosal Injection of Liposomal Adriamycin in Patients with Gastric Carcinoma
por: Akamo, Yoshimi, et al.
Publicado: (1994)

Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin.
por: Gabizon, A., et al.
Publicado: (1991)

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.
por: Gabizon, A., et al.
Publicado: (1985)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Shock Wave and THP‐Adriamycin for Treatment of Rabbit's Bladder Cancer
por: Hoshi, Senji, et al.
Publicado: (1992)

A case of diverticulum of the appendiceal base resembling a submucosal tumor of the cecum under colonoscopy: a hitherto undescribed lesion
por: Kimura, Toshihisa, et al.
Publicado: (2022)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Predictive value of myenteric and submucosal plexitis for postoperative Crohn's disease recurrence
por: Nakao, Sayumi, et al.
Publicado: (2018)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Diffuse large B cell lymphoma primarily presenting as acute liver failure in a surviving patient
por: Shibata, Jumpei, et al.
Publicado: (2019)

Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report
por: Imoto, Naoto, et al.
Publicado: (2021)

Endoscopic Submucosal Dissection for Gastric Arteriovenous Malformation
por: Kojima, Yuichi, et al.
Publicado: (2016)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

A Reddish Submucosal Tumor after Nephrectomy
por: Sadahira, Takuya, et al.
Publicado: (2017)

In vitro Targeting and Cytotoxicity of Adriamycin in Liposomes Bearing Monoclonal Antibody against Rat or Human gp125 Cell Proliferation‐associated Antigen
por: Tanaka, Toshiyuki, et al.
Publicado: (1989)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Immunocytochemical Identification and Localization of the Mr 22,000 Calcium‐binding Protein (Sorcin) in an Adriamycin‐resistant Myelogenous Leukemia Cell Line
por: Sugawara, Isamu, et al.
Publicado: (1989)

Cellular and Tissue Distribution of MRK20 Murine Monoclonal Antibody‐defined 85‐kDa Protein in Adriamycin‐resistant Cancer Cell Lines
por: Sugawara, Isamu, et al.
Publicado: (1988)

A Case of Eosinophilic Granuloma Presenting as a Small Submucosal Tumor
por: Kojima, Yuichi, et al.
Publicado: (2017)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
por: Manh Hung, Le Van, et al.
Publicado: (2018)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Polyoxyethylene‐modified Superoxide Dismutase Reduces Side Effects of Adriamycin and Mitomycin C
por: Kawasaki, Shingo, et al.
Publicado: (1992)

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
por: Martin, W. M., et al.
Publicado: (1980)

Different distribution of adriamycin in normal and leukaemic rats.
por: Sonneveld, P., et al.
Publicado: (1981)

A Sarcoma at the Site of Previous Extravasation of Adriamycin
por: Ceulemans, Joris, et al.
Publicado: (2002)

An in vivo assessment of adriamycin-loaded albumin microspheres.
por: Goldberg, J. A., et al.
Publicado: (1992)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Adriamycin does not damage podocytes of zebrafish larvae
por: Schindler, Maximilian, et al.
Publicado: (2020)

Surveillance of salivary properties of pre-orthodontic patients in relation to age and sex
por: Kado, Isamu, et al.
Publicado: (2021)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Evaluation of gastric submucosal tumors using endoscopically visualized features with submucosal endoscopy
por: KOBARA, HIDEKI, et al.
Publicado: (2014)

In vivo tumour-cell proliferation after adriamycin treatment.
por: Rowley, R., et al.
Publicado: (1982)

The effect of digoxin on the binding of adriamycin to cat heart muscle.
por: Somberg, J., et al.
Publicado: (1977)

Protective effect of melatonin against Adriamycin-induced cardiotoxicity
por: ZHANG, YAN, et al.
Publicado: (2013)

Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_im45dmh4k342emsjlbvgmaop2g